CS Capital logo

CS Capital

Asia, Shanghai, China, Shanghai

Description

CS Capital is an investment firm that offers investment management service.

Investor Profile

CS Capital has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (75%)
  • Private Equity (25%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Manufacturing
  • Pharmaceutical
  • Therapeutics
  • Health Care
  • Medical
  • Fleet Management
  • Information Technology
  • Internet Of Things
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CS Capital frequently co-invest with?

China Merchants Group
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Binfu Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
October Capital
North America, Missouri, United States, Kansas City
Co-Investments: 2
ALAN AMC
Asia, Beijing, China, Beijing
Co-Investments: 2
Co-Stone Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
China Merchants Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
China Merchants Health
Asia, Hunan, China, Nanshan
Co-Investments: 1
LYFE Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Gaorong Capital
Asia, Beijing, China, Wangjing
Co-Investments: 2
China Merchants Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by CS Capital?

Lingmo Medical

Hangzhou, Zhejiang, China

Lingmo Medical is a company that provides department-level flexible endoscopic solutions.

Health CareHospitalMedicalWellness
Series AApr 7, 2025
Biointron

Shanghai, Shanghai, China

Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents.

BiotechnologyHealth CareMedical
Series BAug 31, 2022
Amount Raised: $72,564,728
Baiying Bio

Beijing, Beijing, China

Baiying Bio is a research and development outsourcing service provider.

BiotechnologyOutsourcingService Industry
Series BAug 31, 2022
Amount Raised: $72,564,728
Porton Advanced Solutions

Suzhou, Jiangsu, China

Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

BiotechnologyGeneticsManufacturingPharmaceuticalTherapeutics
Series BAug 21, 2022
Amount Raised: $80,000,000
G7

Haidian, Beijing, China

G7 is a fleet management service provider in China that offers IoT/AI services to over 800,000 vehicles.

Fleet ManagementInformation TechnologyInternet of ThingsLogisticsTransportation
Private EquityFeb 15, 2022
Amount Raised: $200,000,000